TWST - Twist Bioscience inks antibody research deal with Bayer
2023-10-05 12:10:43 ET
More on Bayer
- Bayer: Undervalued With Clear Catalysts
- Twist Bioscience: Progress Hidden By Execution Issues And Soft Demand
- Bayer: Still A Strong Buy Despite Lowered Guidance
- FMC, Bayer downgraded to Neutral at Redburn Atlantic on crop-price outlook
- EU seeks 10-year extension for glyphosate, active ingredient in Bayer's Roundup
For further details see:
Twist Bioscience inks antibody research deal with Bayer